Eli Lilly and Company ( LLY) - Payout Ratio History
Payout ratio history for stock LLY (Eli Lilly and Company).
| Date | Payout ratio |
|---|---|
| September 2024 | 64.12% |
| August 2024 | 76.36% |
| July 2024 | 76.47% |
| June 2024 | 76.92% |
| May 2024 | 89.81% |
| April 2024 | 93.69% |
| March 2024 | 93.69% |
| February 2024 | 93.69% |
| January 2024 | 41.74% |
| December 2023 | 41.74% |
| November 2023 | 35.76% |
| October 2023 | 35.82% |
| September 2023 | 35.56% |
| August 2023 | 36.81% |
| July 2023 | 36.90% |
| June 2023 | 36.81% |
| May 2023 | 38.60% |
| April 2023 | 38.60% |
| March 2023 | 38.50% |
| February 2023 | 54.85% |
| January 2023 | 49.45% |
| December 2022 | 42.66% |
| November 2022 | 41.39% |
| October 2022 | 45.27% |
| September 2022 | 45.27% |
| August 2022 | 52.34% |
| July 2022 | 45.58% |
| June 2022 | 45.58% |
| May 2022 | 45.58% |
| April 2022 | 45.58% |
| March 2022 | 45.58% |
| February 2022 | 39.53% |
| January 2022 | 39.53% |
| December 2021 | 39.53% |
| October 2021 | 51.13% |
| September 2021 | 51.13% |
| August 2021 | 50.90% |
| July 2021 | 50.90% |
| June 2021 | 50.90% |
| May 2021 | 50.07% |
| April 2021 | 50.07% |
| March 2021 | 50.07% |
| February 2021 | 48.45% |
| January 2021 | 48.45% |
| December 2020 | 42.23% |
| November 2020 | 42.11% |
| October 2020 | 41.83% |
| September 2020 | 41.83% |
| August 2020 | 42.64% |
| July 2020 | 42.64% |
| June 2020 | 42.64% |
| May 2020 | 82.43% |
| April 2020 | 82.43% |
| March 2020 | 82.43% |
| February 2020 | 82.43% |
| January 2020 | 82.43% |
| December 2019 | 82.43% |
| November 2019 | 82.43% |
| October 2019 | 82.43% |
| September 2019 | 82.43% |
| August 2019 | 82.43% |
| July 2019 | 82.43% |
| June 2019 | 82.43% |
| May 2019 | 82.43% |
| April 2019 | 82.43% |
| March 2019 | 82.43% |
| February 2019 | 83.50% |
| December 2018 | 469.70% |
| December 2017 | 98.60% |
| December 2016 | 88.30% |
| December 2015 | 89.60% |
| December 2014 | 78.40% |
| December 2013 | 44.80% |
| December 2012 | 53.50% |
| December 2011 | 46.90% |
| December 2010 | 42.70% |
| December 2009 | 49.80% |
| December 2008 | 52.76% |
| December 2007 | 55.20% |
| December 2006 | 61.52% |
| December 2005 | 61.08% |
| December 2004 | 56.03% |
| December 2003 | 57.17% |
| December 2002 | 55.54% |
| December 2001 | 49.98% |
| December 2000 | 48.06% |
| December 1999 | 50.01% |
LLY
List: Contenders
Price: $902.71
Dividend Yield: 0.01%
Forward Dividend Yield: 0.58%
Payout Ratio: 64.12%
Dividend Per Share: 5.20 USD
Earnings Per Share: 8.16 USD
P/E Ratio: 118.08
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 2.6 million
Ebitda: 758.9 millionMarket Capitalization: 867.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 53
DGR3: 23.82%
DGR5: 20.20%
DGR10: 12.63%
DGR20: 8.05%